Hepatitis C virus load in seropositive liver and kidney transplant recipients by quantitative real-time PCR before and after transplantation

Jundishapur Journal of Microbiology

Volumn 6, Issue 8, 2013, Pages

  Behzadi, Mohammad Amin ^a   Ziyaeyan, Mazyar ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis C virus; Iran; Transplantation; Viral load

Indexed keywords

ANTIVIRUS AGENT; VIRUS RNA;

ADOLESCENT; ADULT; AGE; AGED; ANTIVIRAL THERAPY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; COPY NUMBER VARIATION; DRUG RESPONSE; FEMALE; GRAFT RECIPIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEX DIFFERENCE; VIRUS LOAD;

HEPATITIS C VIRUS;

EID: 84888117189     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.7365     Document Type: Article

References (38)

1. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 1994;19(5):1321-4.
2. Ziyaeyan M, Alborzi A, Jamalidoust M, Badiee P, Moeini M, Kadivar A. Prevalence of hepatitis C virus genotypes in chronic infected patients, southern Iran. Jundishapur J Microbiol. 2011;4(3):141-146.
3. Gheorghe L, Csiki IE, Iacob S, Gheorghe C, Smira G, Regep L. The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: a nationwide survey 2006 - 2008. J Gastrointestin Liver Dis. 2010;19(4):373-9.
4. Weigand K, Stremmel W, Encke J. Treatment of hepatitis C virus infection. World J Gastroenterol. 2007;13(13):1897-905.
5. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3(2):47-52.
6. Berenguer M, López-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol. 2001;35(5):666-678.
7. Charlton M. Hepatitis C infection in liver transplantation. Am J Transplant. 2001;1(3):197-203.
8. Sarbah SA, Younossi ZM. Hepatitis C: an update on the silent epidemic. J Clin Gastroenterol. 2000;30(2):125-43.
9. Alvarado-Mora MV, Fernandez MF, Gomes-Gouvea MS, de Azevedo Neto RS, Carrilho FJ, Pinho JR. Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation? PLoS One. 2011;6(4).
10. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kidney Dis. 2003;42(4):631-57.
11. Aroldi A, Lampertico P, Montagnino G, Lunghi G, Passerini P, Villa M, et al. Natural history of hepatitis C virus infection in adult renal graft recipients. Transplant Proc. 2005;37(2):940-1.
12. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant. 2005;5(6):1452-61.
13. Pedroso S, Martins L, Fonseca I, Dias L, Henriques AC, Sarmento AM, et al. Impact of hepatitis C virus on renal transplantation: association with poor survival. Transplant Proc. 2006;38(6):1890-4.
14. Einollahi B, Pourfarziani V, Ahmadzad-Asl M, Davoudi F, Lessan- Pezeshki M, Davoudi A, et al. Iranian model of renal allograft transplantation in 3028 recipients: survival and risk factors. Transplant Proc. 2007;39(4):907-10.
15. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002;36(1):3-10.
16. Thomson BJ, Kwong G, Ratib S, Sweeting M, Ryder SD, De Angelis D, et al. Response rates to combination therapy for chronic HCV infection in a clinical setting and derivation of probability tables for individual patient management. J Viral Hepat. 2008;15(4):271-8.
17. Hayashi N, Takehara T. Antiviral therapy for chronic hepatitis C: past, present, and future. J Gastroenterol. 2006;41(1):17-27.
18. Gordon FD. Cost-effectiveness of screening patients for hepatitis C. Am J Med. 1999;107(6B):36S-40S.
19. Hill L, Henry B, Schweikert S. Screening for chronic hepatitis C: American College of Preventive Medicine practice policy statement. Am J Prev Med. 2005;28(3):327-30.
20. Alavi SM, Hajiani E. Hepatitis C infection: a review on epidemiology and management of occupational exposure in health care workers for general physicians working in Iranian health network setting. Jundishapur J Microbiol. 2011;4(1):1-9.
21. Ziyaeyan M, Jamalidoust M, Moeini M. Evaluation of Hepatitis C Virus Infection in Antibody Positive Orphan Newborns. Jundishapur J Microbiol. 2012;6(1):72-75.
22. Thio CL, Nolt KR, Astemborski J, Vlahov D, Nelson KE, Thomas DL. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol. 2000;38(2):575-7.
23. Kalantar-Zadeh K, Miller LG, Daar ES. Diagnostic discordance for hepatitis C virus infection in hemodialysis patients. Am J Kidney Dis. 2005;46(2):290-300.
24. Albeldawi M, Ruiz-Rodriguez E, Carey WD. Hepatitis C virus: Prevention, screening, and interpretation of assays. Cleve Clin J Med. 2010;77(9):616-26.
25. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49(4):1335-74.
26. Ebadi M, Yaghobi R, Geramizadeh B, Bahmani MK, Malek- Hosseini SA, Nemayandeh M. Prevalence of HCV and HGV infections in Iranian liver transplant recipients. Transplant Proc. 2011;43(2):618-20.
27. Moghaddam SM, Alavian SM, Kermani NA. Hepatitis C and renal transplantation: a review on historical aspects and current issues. Rev Med Virol. 2008;18(6):375-86.
28. Fehr T, Riehle HM, Nigg L, Gruter E, Ammann P, Renner EL, et al. Evaluation of hepatitis B and hepatitis C virus-infected renal allograft recipients with liver biopsy and noninvasive parameters. Am J Kidney Dis. 2003;42(1):193-201.
29. Mitwalli AH, Alam A, Al-Wakeel J, Al Suwaida K, Tarif N, Schaar TA, et al. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients. Nephron Clin Pract. 2006;102(2):c72-80.
30. Demetris AJ. Evolution of hepatitis C virus in liver allografts. Liver Transpl. 2009;15 Suppl 2:S35-41.
31. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology. 2000;31(3):756-62.
32. Ashry Ahmed Gheith O. Dilemma of HCV infection in renal transplant recipients. Int J Nephrol. 2011;2011:471214.
33. Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009. MMWR Morb Mortal Wkly Rep. 2011;60(17):537-41.
34. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant. 2005;5(6):1452-61.
35. Fabrizi F, Lunghi G, Dixit V, Martin P. Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients. Aliment Pharmacol Ther. 2006;24(10):1413-22.
36. Rostami Z, Nourbala MH, Alavian SM, Bieraghdar F, Jahani Y, Einollahi B. The impact of Hepatitis C virus infection on kidney transplantation outcomes: A systematic review of 18 observational studies: The impact of HCV on renal transplantation. Hepat Mon. 2011;11(4):247-54.
37. Terrault NA, Adey DB. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol. 2007;2(3):563-75.
38. Lok AS, Ma OC, Chan TM, Lai CL, Chung HT, Ng CP, et al. Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera. Hepatology. 1991;14(5):756-62.